Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA's Cleveland Clinic and Duke Connection

This article was originally published in RPM Report

Executive Summary

Steven Nissen (Cleveland Clinic) and Robert Califf (Duke) are well known advisers to FDA: outside experts the agency turns to on thorny issues -- especially involving cardiovascular risks. What is less recognized is the prominence of the institutions that Nissen and Califf represent and their impact on the FDA advisory committee process. The agency currently has a dozen advisory committee members from the Cleveland Clinic and Duke.

You may also be interested in...



Who Should Be The Next FDA Commissioner? David Kessler Weighs In

Former FDA Commissioner David Kessler has a few ideas about the kind of person President-elect Barack Obama should pick to succeed Andrew von Eschenbach at FDA after he takes office Jan. 20

FDA Commissioner Search: Myths And Reality

Speculation about the next FDA head is well under way, but before it gets out of hand, here are five rules of thumb to keep in mind.

Who Will Run FDA Under Obama?

Steve Nissen has been getting the most attention, but there are plenty of other possibilities. Here are some of the names we’ve heard.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS080475

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel